Effects	NNS	B-NP	O	Other	###	1	Effects	Effects	NNS	NNS	_	0	root	_	_
of	IN	B-PP	O	Other	###	2	of	of	IN	IN	_	4	case	_	_
intranasal	JJ	B-NP	O	Other	###	3	intranasal	intranasal	JJ	JJ	_	4	amod	_	_
glucocorticoids	NNS	I-NP	O	Other	###	4	glucocorticoids	glucocorticoids	NNS	NNS	_	1	nmod	_	_
on	IN	B-PP	O	Other	###	5	on	on	IN	IN	_	7	case	_	_
endogenous	JJ	B-NP	O	Other	###	6	endogenous	endogenous	JJ	JJ	_	7	amod	_	_
glucocorticoid	NN	I-NP	O	Other	###	7	glucocorticoid	glucocorticoid	NN	NN	_	1	nmod	_	_
peripheral	JJ	I-NP	O	Other	###	8	peripheral	peripheral	JJ	JJ	_	7	dep	_	_
and	CC	I-NP	O	Other	###	9	and	and	CC	CC	_	7	cc	_	_
central	JJ	I-NP	O	Other	###	10	central	central	JJ	JJ	_	7	conj	_	_
function	NN	I-NP	O	Other	###	11	function	function	NN	NN	_	7	dep	_	_
.	.	O	O	Other	###	12	.	.	.	.	_	1	punct	_	_

Glucocorticoids	NNS	B-NP	O	Other	###	1	Glucocorticoids	Glucocorticoids	NNS	NNS	_	8	nsubj	_	_
are	VBP	B-VP	O	Other	###	2	are	are	VBP	VBP	_	8	cop	_	_
among	IN	B-PP	O	Other	###	3	among	among	IN	IN	_	8	case	_	_
the	DT	B-NP	O	Other	###	4	the	the	DT	DT	_	8	det	_	_
most	RBS	I-NP	O	Other	###	5	most	most	RBS	RBS	_	6	advmod	_	_
potent	JJ	I-NP	O	Other	###	6	potent	potent	JJ	JJ	_	7	amod	_	_
antiinflammatory	JJ	I-NP	O	Other	###	7	antiinflammatory	antiinflammatory	JJ	JJ	_	8	amod	_	_
agents	NNS	I-NP	O	Other	###	8	agents	agents	NNS	NNS	_	0	root	_	_
that	WDT	B-NP	O	Other	###	9	that	that	WDT	WDT	_	12	nsubjpass	_	_
can	MD	B-VP	O	Other	###	10	can	can	MD	MD	_	12	aux	_	_
be	VB	I-VP	O	Other	###	11	be	be	VB	VB	_	12	auxpass	_	_
used	VBN	I-VP	O	Other	###	12	used	used	VBN	VBN	_	8	acl:relcl	_	_
in	IN	B-PP	O	Other	###	13	in	in	IN	IN	_	15	case	_	_
the	DT	B-NP	O	Other	###	14	the	the	DT	DT	_	15	det	_	_
treatment	NN	I-NP	O	Other	###	15	treatment	treatment	NN	NN	_	12	nmod	_	_
of	IN	B-PP	O	Other	###	16	of	of	IN	IN	_	17	case	_	_
rhinitis	NN	B-NP	O	Other	###	17	rhinitis	rhinitis	NN	NN	_	15	nmod	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	8	punct	_	_

Their	PRP$	B-NP	O	Other	###	1	Their	Their	PRP$	PRP$	_	2	nmod:poss	_	_
mechanisms	NNS	I-NP	O	Other	###	2	mechanisms	mechanisms	NNS	NNS	_	6	nsubj	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	4	case	_	_
action	NN	B-NP	O	Other	###	4	action	action	NN	NN	_	2	nmod	_	_
are	VBP	B-VP	O	Other	###	5	are	are	VBP	VBP	_	6	cop	_	_
multiple	JJ	B-ADJP	O	Other	###	6	multiple	multiple	JJ	JJ	_	0	root	_	_
and	CC	I-ADJP	O	Other	###	7	and	and	CC	CC	_	6	cc	_	_
complex	JJ	I-ADJP	O	Other	###	8	complex	complex	JJ	JJ	_	6	conj	_	_
and	CC	O	O	Other	###	9	and	and	CC	CC	_	6	cc	_	_
a	DT	B-NP	O	Other	###	10	a	a	DT	DT	_	11	det	_	_
number	NN	I-NP	O	Other	###	11	number	number	NN	NN	_	14	nsubj	_	_
of	IN	B-PP	O	Other	###	12	of	of	IN	IN	_	13	case	_	_
reports	NNS	B-NP	O	Other	###	13	reports	reports	NNS	NNS	_	11	nmod	_	_
describe	VBP	B-VP	O	Other	###	14	describe	describe	VBP	VBP	_	6	conj	_	_
significant	JJ	B-NP	O	Other	###	15	significant	significant	JJ	JJ	_	17	amod	_	_
systemic	JJ	I-NP	O	Other	###	16	systemic	systemic	JJ	JJ	_	15	dep	_	_
effects	NNS	I-NP	O	Other	###	17	effects	effects	NNS	NNS	_	14	dobj	_	_
of	IN	B-PP	O	Other	###	18	of	of	IN	IN	_	21	case	_	_
locally	RB	B-NP	O	Other	###	19	locally	locally	RB	RB	_	21	advmod	_	_
administered	VBN	I-NP	O	Other	###	20	administered	administered	VBN	VBN	_	21	amod	_	_
glucocorticoids	NNS	I-NP	O	Other	###	21	glucocorticoids	glucocorticoids	NNS	NNS	_	17	nmod	_	_
.	.	O	O	Other	###	22	.	.	.	.	_	6	punct	_	_

In	IN	B-SBAR	O	Other	###	1	In	In	IN	IN	_	4	mark	_	_
order	NN	O	O	Other	###	2	order	order	NN	NN	_	1	mwe	_	_
to	TO	B-VP	O	Other	###	3	to	to	TO	TO	_	4	mark	_	_
evaluate	VB	I-VP	O	Other	###	4	evaluate	evaluate	VB	VB	_	19	advcl	_	_
the	DT	B-NP	O	Other	###	5	the	the	DT	DT	_	8	det	_	_
short-term	JJ	I-NP	O	Other	###	6	short-term	short-term	JJ	JJ	_	7	amod	_	_
systemic	JJ	I-NP	O	Other	###	7	systemic	systemic	JJ	JJ	_	8	amod	_	_
effects	NNS	I-NP	O	Other	###	8	effects	effects	NNS	NNS	_	4	dobj	_	_
of	IN	B-PP	O	Other	###	9	of	of	IN	IN	_	12	case	_	_
intranasally	RB	B-NP	O	Other	###	10	intranasally	intranasally	RB	RB	_	11	advmod	_	_
administered	VBN	I-NP	O	Other	###	11	administered	administered	VBN	VBN	_	12	amod	_	_
glucocorticoids	NNS	I-NP	O	Other	###	12	glucocorticoids	glucocorticoids	NNS	NNS	_	8	nmod	_	_
,	,	O	O	Other	###	13	,	,	,	,	_	19	punct	_	_
14	CD	B-NP	O	Other	###	14	14	14	CD	CD	_	17	nummod	_	_
normal	JJ	I-NP	O	Other	###	15	normal	normal	JJ	JJ	_	17	amod	_	_
healthy	JJ	I-NP	O	Other	###	16	healthy	healthy	JJ	JJ	_	17	amod	_	_
subjects	NNS	I-NP	O	Other	###	17	subjects	subjects	NNS	NNS	_	19	nsubjpass	_	_
were	VBD	B-VP	O	Other	###	18	were	were	VBD	VBD	_	19	auxpass	_	_
treated	VBN	I-VP	O	Other	###	19	treated	treated	VBN	VBN	_	0	root	_	_
with	IN	B-PP	O	Other	###	20	with	with	IN	IN	_	22	case	_	_
two	CD	B-NP	O	Other	###	21	two	two	CD	CD	_	22	nummod	_	_
doses	NNS	I-NP	O	Other	###	22	doses	doses	NNS	NNS	_	19	nmod	_	_
of	IN	B-PP	O	Other	###	23	of	of	IN	IN	_	25	case	_	_
either	CC	O	O	Other	###	24	either	either	CC	CC	_	25	cc:preconj	_	_
budesonide	NN	B-NP	O	Other	###	25	budesonide	budesonide	NN	NN	_	22	nmod	_	_
(	(	O	O	Other	###	26	(	(	(	(	_	27	punct	_	_
BUD	NN	B-NP	O	Other	###	27	BUD	BUD	NN	NN	_	25	appos	_	_
)	)	O	O	Other	###	28	)	)	)	)	_	27	punct	_	_
or	CC	O	O	Other	###	29	or	or	CC	CC	_	25	cc	_	_
fluticasone	NN	B-NP	O	Other	###	30	fluticasone	fluticasone	NN	NN	_	31	compound	_	_
propionate	NN	I-NP	O	Other	###	31	propionate	propionate	NN	NN	_	25	conj	_	_
(	(	O	O	Other	###	32	(	(	(	(	_	33	punct	_	_
FP	NN	B-NP	O	Other	###	33	FP	FP	NN	NN	_	31	appos	_	_
)	)	O	O	Other	###	34	)	)	)	)	_	33	punct	_	_
for	IN	B-PP	O	Other	###	35	for	for	IN	IN	_	37	case	_	_
2	CD	B-NP	O	Other	###	36	2	2	CD	CD	_	37	nummod	_	_
weeks	NNS	I-NP	O	Other	###	37	weeks	weeks	NNS	NNS	_	19	nmod	_	_
.	.	O	O	Other	###	38	.	.	.	.	_	19	punct	_	_

Before	IN	B-PP	O	Other	###	1	Before	Before	IN	IN	_	2	case	_	_
treatment	NN	B-NP	O	Other	###	2	treatment	treatment	NN	NN	_	39	nmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	2	punct	_	_
at	IN	B-PP	O	Other	###	4	at	at	IN	IN	_	6	case	_	_
regular	JJ	B-NP	O	Other	###	5	regular	regular	JJ	JJ	_	6	amod	_	_
intervals	NNS	I-NP	O	Other	###	6	intervals	intervals	NNS	NNS	_	2	dep	_	_
during	IN	B-PP	O	Other	###	7	during	during	IN	IN	_	9	case	_	_
the	DT	B-NP	O	Other	###	8	the	the	DT	DT	_	9	det	_	_
treatment	NN	I-NP	O	Other	###	9	treatment	treatment	NN	NN	_	6	nmod	_	_
,	,	O	O	Other	###	10	,	,	,	,	_	2	punct	_	_
1	CD	B-NP	O	Other	###	11	1	1	CD	CD	_	12	nummod	_	_
week	NN	I-NP	O	Other	###	12	week	week	NN	NN	_	2	dep	_	_
and	CC	O	O	Other	###	13	and	and	CC	CC	_	12	cc	_	_
finally	RB	B-NP	O	Other	###	14	finally	finally	RB	RB	_	16	advmod	_	_
6	CD	I-NP	O	Other	###	15	6	6	CD	CD	_	16	nummod	_	_
weeks	NNS	I-NP	O	Other	###	16	weeks	weeks	NNS	NNS	_	12	conj	_	_
after	IN	B-PP	O	Other	###	17	after	after	IN	IN	_	18	case	_	_
termination	NN	B-NP	O	Other	###	18	termination	termination	NN	NN	_	12	nmod	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	20	case	_	_
treatment	NN	B-NP	O	Other	###	20	treatment	treatment	NN	NN	_	18	nmod	_	_
,	,	O	O	Other	###	21	,	,	,	,	_	39	punct	_	_
the	DT	B-NP	O	Other	###	22	the	the	DT	DT	_	23	det	_	_
effects	NNS	I-NP	O	Other	###	23	effects	effects	NNS	NNS	_	39	nsubjpass	_	_
on	IN	B-PP	O	Other	###	24	on	on	IN	IN	_	26	case	_	_
glucocorticoid	NN	B-NP	B-protein	B-Protein	###	25	glucocorticoid	glucocorticoid	NN	NN	_	26	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	26	receptor	receptor	NN	NN	_	23	nmod	_	_
(	(	O	O	Other	###	27	(	(	(	(	_	28	punct	_	_
GR	NN	B-NP	B-protein	B-Protein	###	28	GR	GR	NN	NN	_	26	appos	_	_
)	)	O	O	Other	###	29	)	)	)	)	_	28	punct	_	_
and	CC	O	O	Other	###	30	and	and	CC	CC	_	26	cc	_	_
methallothionein	NN	B-NP	O	B-Protein	###	31	methallothionein	methallothionein	NN	NN	_	36	compound	_	_
(	(	O	O	Other	###	32	(	(	(	(	_	33	punct	_	_
MTIIa	NN	B-NP	O	B-Protein	###	33	MTIIa	MTIIa	NN	NN	_	31	appos	_	_
)	)	O	O	Other	###	34	)	)	)	)	_	33	punct	_	_
mRNA	NN	B-NP	O	Other	###	35	mRNA	mRNA	NN	NN	_	36	compound	_	_
expression	NN	I-NP	O	Other	###	36	expression	expression	NN	NN	_	26	conj	_	_
levels	NNS	I-NP	O	Other	###	37	levels	levels	NNS	NNS	_	26	dep	_	_
were	VBD	B-VP	O	Other	###	38	were	were	VBD	VBD	_	39	auxpass	_	_
examined	VBN	I-VP	O	Other	###	39	examined	examined	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	###	40	in	in	IN	IN	_	42	case	_	_
peripheral	JJ	B-NP	B-cell_type	Other	###	41	peripheral	peripheral	JJ	JJ	_	42	amod	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	###	42	lymphocytes	lymphocytes	NNS	NNS	_	39	nmod	_	_
using	VBG	B-VP	O	Other	###	43	using	using	VBG	VBG	_	39	xcomp	_	_
a	DT	B-NP	O	Other	###	44	a	a	DT	DT	_	47	det	_	_
solution	NN	I-NP	O	Other	###	45	solution	solution	NN	NN	_	47	compound	_	_
hybridization	NN	I-NP	O	Other	###	46	hybridization	hybridization	NN	NN	_	47	compound	_	_
assay	NN	I-NP	O	Other	###	47	assay	assay	NN	NN	_	43	dobj	_	_
.	.	O	O	Other	###	48	.	.	.	.	_	39	punct	_	_

Serum	NN	B-NP	O	Other	###	1	Serum	Serum	NN	NN	_	2	compound	_	_
cortisol	NN	I-NP	O	Other	###	2	cortisol	cortisol	NN	NN	_	11	nsubjpass	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	2	punct	_	_
osteocalcin	NN	B-NP	B-protein	B-Protein	###	4	osteocalcin	osteocalcin	NN	NN	_	2	conj	_	_
and	CC	O	O	Other	###	5	and	and	CC	CC	_	2	cc	_	_
urinary	JJ	B-NP	O	Other	###	6	urinary	urinary	JJ	JJ	_	7	amod	_	_
cortisol	NN	I-NP	O	Other	###	7	cortisol	cortisol	NN	NN	_	2	conj	_	_
levels	NNS	I-NP	O	Other	###	8	levels	levels	NNS	NNS	_	2	dep	_	_
were	VBD	B-VP	O	Other	###	9	were	were	VBD	VBD	_	11	auxpass	_	_
also	RB	I-VP	O	Other	###	10	also	also	RB	RB	_	11	advmod	_	_
determined	VBN	I-VP	O	Other	###	11	determined	determined	VBN	VBN	_	0	root	_	_
.	.	O	O	Other	###	12	.	.	.	.	_	11	punct	_	_

An	DT	B-NP	O	Other	###	1	An	An	DT	DT	_	4	det	_	_
insulin	NN	I-NP	O	Other	###	2	insulin	insulin	NN	NN	_	4	compound	_	_
tolerance	NN	I-NP	O	Other	###	3	tolerance	tolerance	NN	NN	_	4	compound	_	_
test	NN	I-NP	O	Other	###	4	test	test	NN	NN	_	9	nsubjpass	_	_
(	(	O	O	Other	###	5	(	(	(	(	_	6	punct	_	_
ITT	NN	B-NP	O	Other	###	6	ITT	ITT	NN	NN	_	4	appos	_	_
)	)	O	O	Other	###	7	)	)	)	)	_	6	punct	_	_
was	VBD	B-VP	O	Other	###	8	was	was	VBD	VBD	_	9	auxpass	_	_
performed	VBN	I-VP	O	Other	###	9	performed	performed	VBN	VBN	_	0	root	_	_
at	IN	B-PP	O	Other	###	10	at	at	IN	IN	_	12	case	_	_
the	DT	B-NP	O	Other	###	11	the	the	DT	DT	_	12	det	_	_
end	NN	I-NP	O	Other	###	12	end	end	NN	NN	_	9	nmod	_	_
of	IN	B-PP	O	Other	###	13	of	of	IN	IN	_	16	case	_	_
the	DT	B-NP	O	Other	###	14	the	the	DT	DT	_	16	det	_	_
second	JJ	I-NP	O	Other	###	15	second	second	JJ	JJ	_	16	amod	_	_
week	NN	I-NP	O	Other	###	16	week	week	NN	NN	_	12	nmod	_	_
of	IN	B-PP	O	Other	###	17	of	of	IN	IN	_	18	case	_	_
treatment	NN	B-NP	O	Other	###	18	treatment	treatment	NN	NN	_	16	nmod	_	_
and	CC	O	O	Other	###	19	and	and	CC	CC	_	12	cc	_	_
at	IN	B-PP	O	Other	###	20	at	at	IN	IN	_	22	case	_	_
the	DT	B-NP	O	Other	###	21	the	the	DT	DT	_	22	det	_	_
end	NN	I-NP	O	Other	###	22	end	end	NN	NN	_	12	conj	_	_
of	IN	B-PP	O	Other	###	23	of	of	IN	IN	_	27	case	_	_
the	DT	B-NP	O	Other	###	24	the	the	DT	DT	_	27	det	_	_
6-week	JJ	I-NP	O	Other	###	25	6-week	6-week	JJ	JJ	_	27	amod	_	_
washout	NN	I-NP	O	Other	###	26	washout	washout	NN	NN	_	27	compound	_	_
period	NN	I-NP	O	Other	###	27	period	period	NN	NN	_	22	nmod	_	_
with	IN	B-PP	O	Other	###	28	with	with	IN	IN	_	32	case	_	_
no	DT	B-NP	O	Other	###	29	no	no	DT	DT	_	32	neg	_	_
statistically	RB	I-NP	O	Other	###	30	statistically	statistically	RB	RB	_	31	advmod	_	_
significant	JJ	I-NP	O	Other	###	31	significant	significant	JJ	JJ	_	32	amod	_	_
change	NN	I-NP	O	Other	###	32	change	change	NN	NN	_	9	nmod	_	_
in	IN	B-PP	O	Other	###	33	in	in	IN	IN	_	35	case	_	_
cortisol	NN	B-NP	O	Other	###	34	cortisol	cortisol	NN	NN	_	35	compound	_	_
response	NN	I-NP	O	Other	###	35	response	response	NN	NN	_	32	nmod	_	_
.	.	O	O	Other	###	36	.	.	.	.	_	9	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	3	case	_	_
peripheral	JJ	B-NP	B-cell_type	Other	###	2	peripheral	peripheral	JJ	JJ	_	3	amod	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	###	3	lymphocytes	lymphocytes	NNS	NNS	_	10	nmod	_	_
,	,	O	O	Other	###	4	,	,	,	,	_	10	punct	_	_
GR	NN	B-NP	B-RNA	B-Protein	###	5	GR	GR	NN	NN	_	7	compound	_	_
mRNA	NN	I-NP	I-RNA	Other	###	6	mRNA	mRNA	NN	NN	_	7	compound	_	_
levels	NNS	I-NP	O	Other	###	7	levels	levels	NNS	NNS	_	10	nsubjpass	_	_
were	VBD	B-VP	O	Other	###	8	were	were	VBD	VBD	_	10	auxpass	_	_
significantly	RB	I-VP	O	Other	###	9	significantly	significantly	RB	RB	_	10	advmod	_	_
down-regulated	VBN	I-VP	O	Other	###	10	down-regulated	down-regulated	VBN	VBN	_	0	root	_	_
.	.	O	O	Other	###	11	.	.	.	.	_	10	punct	_	_

MTIIa	NN	B-NP	B-RNA	B-Protein	###	1	MTIIa	MTIIa	NN	NN	_	3	compound	_	_
mRNA	NN	I-NP	I-RNA	Other	###	2	mRNA	mRNA	NN	NN	_	3	compound	_	_
levels	NNS	I-NP	O	Other	###	3	levels	levels	NNS	NNS	_	4	nsubj	_	_
increased	VBD	B-VP	O	Other	###	4	increased	increased	VBD	VBD	_	0	root	_	_
significantly	RB	B-ADVP	O	Other	###	5	significantly	significantly	RB	RB	_	4	advmod	_	_
.	.	O	O	Other	###	6	.	.	.	.	_	4	punct	_	_

Serum	NN	B-NP	B-protein	Other	###	1	Serum	Serum	NN	NN	_	2	compound	_	_
osteocalcin	NN	I-NP	I-protein	B-Protein	###	2	osteocalcin	osteocalcin	NN	NN	_	3	nsubj	_	_
decreased	VBD	B-VP	O	Other	###	3	decreased	decreased	VBD	VBD	_	0	root	_	_
significantly	RB	B-ADVP	O	Other	###	4	significantly	significantly	RB	RB	_	3	advmod	_	_
during	IN	B-PP	O	Other	###	5	during	during	IN	IN	_	6	case	_	_
treatment	NN	B-NP	O	Other	###	6	treatment	treatment	NN	NN	_	3	nmod	_	_
with	IN	B-PP	O	Other	###	7	with	with	IN	IN	_	9	case	_	_
both	CC	O	O	Other	###	8	both	both	CC	CC	_	9	cc:preconj	_	_
BUD	NN	B-NP	O	Other	###	9	BUD	BUD	NN	NN	_	6	nmod	_	_
and	CC	I-NP	O	Other	###	10	and	and	CC	CC	_	9	cc	_	_
FP	NN	I-NP	O	Other	###	11	FP	FP	NN	NN	_	9	conj	_	_
.	.	O	O	Other	###	12	.	.	.	.	_	3	punct	_	_

Serum	NN	B-NP	O	Other	###	1	Serum	Serum	NN	NN	_	2	compound	_	_
cortisol	NN	I-NP	O	Other	###	2	cortisol	cortisol	NN	NN	_	3	nsubj	_	_
decreased	VBD	B-VP	O	Other	###	3	decreased	decreased	VBD	VBD	_	0	root	_	_
after	IN	B-SBAR	O	Other	###	4	after	after	IN	IN	_	6	case	_	_
1	CD	B-NP	O	Other	###	5	1	1	CD	CD	_	6	nummod	_	_
week	NN	I-NP	O	Other	###	6	week	week	NN	NN	_	3	nmod	_	_
of	IN	B-PP	O	Other	###	7	of	of	IN	IN	_	8	case	_	_
treatment	NN	B-NP	O	Other	###	8	treatment	treatment	NN	NN	_	6	nmod	_	_
whereas	IN	B-PP	O	Other	###	9	whereas	whereas	IN	IN	_	14	mark	_	_
urinary	JJ	B-NP	O	Other	###	10	urinary	urinary	JJ	JJ	_	11	amod	_	_
cortisol	NN	I-NP	O	Other	###	11	cortisol	cortisol	NN	NN	_	14	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	12	was	was	VBD	VBD	_	14	auxpass	_	_
not	RB	I-VP	O	Other	###	13	not	not	RB	RB	_	14	neg	_	_
affected	VBN	I-VP	O	Other	###	14	affected	affected	VBN	VBN	_	3	advcl	_	_
until	IN	B-SBAR	O	Other	###	15	until	until	IN	IN	_	18	case	_	_
the	DT	B-NP	O	Other	###	16	the	the	DT	DT	_	18	det	_	_
second	JJ	I-NP	O	Other	###	17	second	second	JJ	JJ	_	18	amod	_	_
week	NN	I-NP	O	Other	###	18	week	week	NN	NN	_	14	nmod	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	20	case	_	_
treatment	NN	B-NP	O	Other	###	20	treatment	treatment	NN	NN	_	18	nmod	_	_
.	.	O	O	Other	###	21	.	.	.	.	_	3	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	2	case	_	_
conclusion	NN	B-NP	O	Other	###	2	conclusion	conclusion	NN	NN	_	10	nmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	10	punct	_	_
intranasal	JJ	B-NP	O	Other	###	4	intranasal	intranasal	JJ	JJ	_	5	amod	_	_
glucocorticoids	NNS	I-NP	O	Other	###	5	glucocorticoids	glucocorticoids	NNS	NNS	_	10	nsubj	_	_
at	IN	B-PP	O	Other	###	6	at	at	IN	IN	_	9	case	_	_
clinically	RB	B-NP	O	Other	###	7	clinically	clinically	RB	RB	_	8	advmod	_	_
recommended	VBN	I-NP	O	Other	###	8	recommended	recommended	VBN	VBN	_	9	amod	_	_
doses	NNS	I-NP	O	Other	###	9	doses	doses	NNS	NNS	_	5	nmod	_	_
have	VBP	B-VP	O	Other	###	10	have	have	VBP	VBP	_	0	root	_	_
not	RB	I-VP	O	Other	###	11	not	not	RB	RB	_	12	neg	_	_
only	RB	I-VP	O	Other	###	12	only	only	RB	RB	_	10	dep	_	_
significant	JJ	B-NP	O	Other	###	13	significant	significant	JJ	JJ	_	15	amod	_	_
systemic	JJ	I-NP	O	Other	###	14	systemic	systemic	JJ	JJ	_	15	amod	_	_
effects	NNS	I-NP	O	Other	###	15	effects	effects	NNS	NNS	_	10	dobj	_	_
on	IN	B-PP	O	Other	###	16	on	on	IN	IN	_	18	case	_	_
adrenal	JJ	B-NP	O	Other	###	17	adrenal	adrenal	JJ	JJ	_	18	amod	_	_
function	NN	I-NP	O	Other	###	18	function	function	NN	NN	_	15	nmod	_	_
,	,	O	O	Other	###	19	,	,	,	,	_	10	punct	_	_
but	CC	B-CONJP	O	Other	###	20	but	but	CC	CC	_	10	cc	_	_
also	RB	I-CONJP	O	Other	###	21	also	also	RB	RB	_	22	advmod	_	_
have	VBP	B-VP	O	Other	###	22	have	have	VBP	VBP	_	10	conj	_	_
an	DT	B-NP	O	Other	###	23	an	an	DT	DT	_	24	det	_	_
effect	NN	I-NP	O	Other	###	24	effect	effect	NN	NN	_	22	dobj	_	_
on	IN	B-PP	O	Other	###	25	on	on	IN	IN	_	28	case	_	_
specific	JJ	B-NP	O	Other	###	26	specific	specific	JJ	JJ	_	28	amod	_	_
gene	NN	I-NP	O	Other	###	27	gene	gene	NN	NN	_	28	compound	_	_
expression	NN	I-NP	O	Other	###	28	expression	expression	NN	NN	_	22	nmod	_	_
in	IN	B-PP	O	Other	###	29	in	in	IN	IN	_	31	case	_	_
peripheral	JJ	B-NP	B-cell_type	Other	###	30	peripheral	peripheral	JJ	JJ	_	31	amod	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	###	31	lymphocytes	lymphocytes	NNS	NNS	_	28	nmod	_	_
.	.	O	O	Other	###	32	.	.	.	.	_	10	punct	_	_

These	DT	B-NP	O	Other	###	1	These	These	DT	DT	_	2	det	_	_
effects	NNS	I-NP	O	Other	###	2	effects	effects	NNS	NNS	_	4	nsubj	_	_
are	VBP	B-VP	O	Other	###	3	are	are	VBP	VBP	_	4	cop	_	_
receptor	JJ	B-ADJP	O	Other	###	4	receptor	receptor	JJ	JJ	_	0	root	_	_
-	-	O	O	Other	###	5	-	-	-	-	_	4	punct	_	_
dependent	JJ	B-ADJP	O	Other	###	6	dependent	dependent	JJ	JJ	_	4	dep	_	_
,	,	O	O	Other	###	7	,	,	,	,	_	6	punct	_	_
reversible	JJ	B-ADJP	O	Other	###	8	reversible	reversible	JJ	JJ	_	6	conj	_	_
,	,	O	O	Other	###	9	,	,	,	,	_	6	punct	_	_
and	CC	O	O	Other	###	10	and	and	CC	CC	_	6	cc	_	_
according	VBG	B-PP	O	Other	###	11	according	according	VBG	VBG	_	13	case	_	_
to	TO	B-PP	O	Other	###	12	to	to	TO	TO	_	11	mwe	_	_
serum	NN	B-NP	O	Other	###	13	serum	serum	NN	NN	_	4	conj	_	_
and	CC	I-NP	O	Other	###	14	and	and	CC	CC	_	13	cc	_	_
urinary	JJ	I-NP	O	Other	###	15	urinary	urinary	JJ	JJ	_	16	amod	_	_
cortisol	NN	I-NP	O	Other	###	16	cortisol	cortisol	NN	NN	_	13	conj	_	_
levels	NNS	I-NP	O	Other	###	17	levels	levels	NNS	NNS	_	13	dep	_	_
and	CC	O	O	Other	###	18	and	and	CC	CC	_	13	cc	_	_
ITT	NN	B-NP	O	Other	###	19	ITT	ITT	NN	NN	_	13	conj	_	_
,	,	O	O	Other	###	20	,	,	,	,	_	13	punct	_	_
leave	VBP	B-VP	O	Other	###	21	leave	leave	VBP	VBP	_	4	conj	_	_
the	DT	B-NP	O	Other	###	22	the	the	DT	DT	_	24	det	_	_
hypothalamic-pituitary-adrenal	JJ	I-NP	O	Other	###	23	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	JJ	JJ	_	24	amod	_	_
function	NN	I-NP	O	Other	###	24	function	function	NN	NN	_	21	dobj	_	_
intact	JJ	B-ADJP	O	Other	###	25	intact	intact	JJ	JJ	_	21	xcomp	_	_
.	.	O	O	Other	###	26	.	.	.	.	_	4	punct	_	_

Finally	RB	B-ADVP	O	Other	###	1	Finally	Finally	RB	RB	_	9	advmod	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	9	punct	_	_
these	DT	B-NP	O	Other	###	3	these	these	DT	DT	_	6	det	_	_
short-term	JJ	I-NP	O	Other	###	4	short-term	short-term	JJ	JJ	_	6	amod	_	_
systemic	JJ	I-NP	O	Other	###	5	systemic	systemic	JJ	JJ	_	6	amod	_	_
effects	NNS	I-NP	O	Other	###	6	effects	effects	NNS	NNS	_	9	nsubjpass	_	_
were	VBD	B-VP	O	Other	###	7	were	were	VBD	VBD	_	9	auxpass	_	_
not	RB	I-VP	O	Other	###	8	not	not	RB	RB	_	9	neg	_	_
associated	VBN	I-VP	O	Other	###	9	associated	associated	VBN	VBN	_	0	root	_	_
with	IN	B-PP	O	Other	###	10	with	with	IN	IN	_	11	case	_	_
any	DT	B-NP	O	Other	###	11	any	any	DT	DT	_	9	nmod	_	_
of	IN	B-PP	O	Other	###	12	of	of	IN	IN	_	15	case	_	_
the	DT	B-NP	O	Other	###	13	the	the	DT	DT	_	15	det	_	_
noticeable	JJ	I-NP	O	Other	###	14	noticeable	noticeable	JJ	JJ	_	15	amod	_	_
side	NNS	I-NP	O	Other	###	15	side	side	NNS	NNS	_	11	nmod	_	_
-	-	O	O	Other	###	16	-	-	-	-	_	15	punct	_	_
effects	NNS	I-NP	O	Other	###	17	effects	effects	NNS	NNS	_	11	nmod	_	_
usually	RB	B-VP	O	Other	###	18	usually	usually	RB	RB	_	19	advmod	_	_
observed	VBN	I-VP	O	Other	###	19	observed	observed	VBN	VBN	_	17	acl	_	_
during	IN	B-PP	O	Other	###	20	during	during	IN	IN	_	22	case	_	_
long-term	JJ	B-NP	O	Other	###	21	long-term	long-term	JJ	JJ	_	22	amod	_	_
treatment	NN	I-NP	O	Other	###	22	treatment	treatment	NN	NN	_	19	nmod	_	_
with	IN	B-PP	O	Other	###	23	with	with	IN	IN	_	24	case	_	_
glucocorticoids	NNS	B-NP	O	Other	###	24	glucocorticoids	glucocorticoids	NNS	NNS	_	22	nmod	_	_
.	.	O	O	Other	###	25	.	.	.	.	_	9	punct	_	_

